Recensie s 'This is a clinically oriented volume, which is well researched, written and edited Feinstein should be congratulated for his effort in reviewing and bringing together what is known of the psychiatry of MS Feinstein deserves particular commendation for his strong pragmatic and clinical bias All in all, I recommend this book to complement any MS library.
Dr Feinstein succeeds in educating the reader why neuropsychiatric disorders assume a key role in the management of MS. I recommend this book to complement the library of not only neurologists and psychiatrists, but to anyone involved in the care of persons with MS. This text can serve as a dependable guide to assist in the recognition and treatment of neuropsychiatric disorders associated with MS that have such an impact in this population's quality of life.
Neuropsychiatric Manifestations of Multiple Sclerosis
The Clinical Neuropsychiatry of Multiple Sclerosis is both wide enough in scope and well organized to be practical in clinical settings yet detailed and referenced enough to be useful in research and teaching Both a comprehensive overview and a practical reference volume to be consulted readily and regularly Archives of Neurology. Reviews Schrijf een review.
Bindwijze: Hardcover. Verkoop door partner van bol.holmmensrocheck.tk
Collaboration is Key to Addressing Mental Health in Multiple Sclerosis
In winkelwagen Op verlanglijstje. Andere verkopers 1. The GeNeuro agent showed marked reductions in brain atrophy in the thalamus and cerebral cortex through a long-term extension period treating patients with multiple sclerosis.
- The Clinical Neuropsychiatry of Multiple Sclerosis by Anthony. | eBay.
- Hypocrisy and the Motive for Self-Integrity.
- - Document - The Clinical Neuropsychiatry of Multiple Sclerosis;
- Nihilism Now!: Monsters of Energy.
- Refine your editions:.
- Words Onscreen: The Fate of Reading in a Digital World.
- The Clinical Neuropsychiatry of Multiple Sclerosis - Anthony Feinstein - Google книги.
The professor and senior physician in the department of clinical neuroscience at the Karolinska Institutet spoke to the aspects of MS—such as brain volume loss—which are not currently being addressed by the available disease-modifying therapies. After showing significant benefits in delayed disease progression in patients with secondary progressive MS, new data suggests siponimod can delay the time to wheelchair dependence by 4 years. Sign In Register.
Feinstein's extensive experience in this area is readily demonstrated by his many important articles over his career. Throughout each chapter he consistently and successfully combines an insightful analysis of the literature with his experience and informed opinion into a summary of the main findings. One of the highlights of this text is his ability to consistently do just that in a manner that is thoughtful and thought provoking.
Shop with confidence
Arch Neurol. All Rights Reserved. Twitter Facebook Email.
This Issue. Citations 0.
The clinical neuropsychiatry of multiple sclerosis.
View Metrics. Book Reviews. Learn more.